Global Pain Management Drugs Market Overview:
Pain is complex, so there are many treatment options medications, therapies, and mind-body techniques. Pain management can be easy or complex, depending on the cause of the pain. An example of pain that is typically less complex would be nerve root irritation from a herniated disc with pain radiating down the leg. This situation can often be alleviated with an epidural steroid injection and physical therapy. Sometimes, still, the pain does not go away which requires a wide variety of skills and techniques to treat the pain. The pain management drugs help in treating various painful conditions. Some of the players profiled in the study are Pfizer (United States), GSK (United Kingdom), Grunenthal (Germany), Bayer (Germany), Sanofi (France), Eli Lilly (United States), AstraZeneca (United Kingdom), Endo (Ireland), Merck (United States) and Depomed (United States).
On the basis of geography, the market of Pain Management Drugs has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Distribution Channel, the sub-segment i.e. Hospitals will boost the Pain Management Drugs market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Drug Class , the sub-segment i.e. Anesthetics will boost the Pain Management Drugs market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Market Growth Drivers
- Increasing Demand for Long-Term Pain Management among the Geriatric Population
- Adverse Effects of Pain Medicines
- High Proven Effectiveness of Pain Management Drugs for the Treatment of Chronic Pain
- Consumption of Over-The-Counter (OTC) Drugs Rather Than Prescription Drugs Among Patients
- Development of New Pain Management Drugs
- Low Awareness about the Use of Pain Management Drugs
- Dearth of Pain Specialists and Low Number of Pain Clinics in Several Countries
- High Growth in Number of Patients Suffering From Neuropathic Pain
- Strict Regulations to Limit Opioid Pain Killer Prescriptions
- Availability of Alternative Therapies for Pain Management
The market is fragmented by both small and big players who have locked horns with each other in the market and are making tireless efforts to gain supremacy over their counterparts. This cut-throat competition is expected to prove beneficial for the consumers who will now have a wide range of vendors, each of whom is willing to go an extra mile to attract the consumers. The strategy that can help these players in growing their customer base and expansion of their product portfolio.
Target Audience:Manufacturers of Pain Management Drugs, Suppliers of Pain Management Drugs, Wholesalers, Distributors, and Retailers of Pain Management Drugs, Healthcare Industry, Governmental Bodies and Research Firms
Major Objectives Focused through this Study To define, describe, and forecast the Global Pain Management Drugs market on the basis of product [Generic Opioids and Branded Opioids] , application [Burn Pain, Cancer Pain, Dental/Facial Pain, Migraine Headache Pain, Musculoskeletal Pain, Neuropathic Pain, Obstetrical Pain and Others], key regions and end user
To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
To provide market size for various segments of the Pain Management Drugs market with respect to major geographies, namely, South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)
To strategically profile the key players and analyzing their market shares and core competencies in the Pain Management Drugs industry
To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market
Available Customization: Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**. Additionally, the Players which are also part of the research are Yunnan Baiyao, Teva, J&J, Allergan and Purdue.
** Confirmation on availability of data would be informed prior purchase
While framing the research framework, major and emerging players operating in the Pain Management Drugs market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.